Profil
Peter A.
Harris was appointed Chief Medical Officer for Oxigene, Inc. in June 2006.
He is a Fellow of the Royal Society of Medicine.
He is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians and a Senior Specialty Advisor.
Dr. Harris held various positions at Roche Products Ltd.
from 1978 to 1985, including the Head of Drug Safety and the Head of Medical Affairs.
From July 2001 to May 2006, he was a Development Director for KuDOS Pharmaceuticals.
He was Director of Clinical Research Europe for Amgen Ltd.
from 1992 to 1994.
Dr. Harris was the Head of Medical Affairs for ICI Pharmaceuticals from 1987 to 1992.
He was Medical Director for Revlon Healthcare from 1985 to 1987 and Medical Director for COBRA Therapeutics from 1994 to 2001.
He received a BS degree from the University of London, a Bachelor of Medicine/Bachelor of Surgery degree from The Royal London Hospital Medical School at the University of London and a Diploma in Pharmaceutical Medicine from the Royal College of Physicians.
Anciens postes connus de Peter A. Harris
Sociétés | Poste | Fin |
---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/08/2007 |
Formation de Peter A. Harris
University of London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |